Dr. Crawford is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 W Arbor Dr
San Diego, CA 92103Phone+1 720-848-0000Fax+1 888-539-8781
Summary
- I am a board-certified urologist who has devoted my career in medicine to educating the public about men's health issues and finding effective techniques and procedures to address prostate cancer, the most common malignancy affecting men in the United States.
I am an internationally recognized expert in benign prostate hypertrophy, urologic cancers, and in particular, prostate cancer.
As a professor in the Department of Urology, I instruct medical students, residents and fellows at UC San Diego School of Medicine. I have conducted research in the treatment of advanced bladder cancer, metastatic adenocarcinoma of the prostate, hormone refractory prostate cancer, and other areas of urological infections and malignancies. I have authored or coauthored over 810 scientific articles, published seven textbooks, authored over 60 book chapters and provided more than 2,200 educational talks for patients and physicians. I serve as editor in chief of Grand Rounds in Urology since June of 2019.
In an effort to raise public awareness about prostate health, Ifounded the Prostate Conditions Education Council (PCEC) in 1989. The non-profit organization is comprised of a consortium of leading physicians, health educators, scientists and men's health advocates. PCEC's advocacy for free or low-cost prostate screening has affected the lives of millions of American men. I currently chair the PCEC.
Consistently recognized as one of the Best Doctors of America for the past two decades, I was ranked as one of the top 20 urologists in the country by Men’s Health Magazine. In May of 2019, I received the presidential citation from the American Urological Association in recognition of his “tireless role in genitourinary cancer research that has benefited countless urologic cancer patients
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Urology, 1977 - 1978
- University of Cincinnati Medical Center/College of MedicineResidency, Urology, 1974 - 1977
- TriHealth (Bethesda North Hospital)Internship, Transitional Year, 1973 - 1974
- University of Cincinnati College of MedicineClass of 1973
Certifications & Licensure
- CA State Medical License 2019 - 2025
- CO State Medical License 1986 - 2025
- FL State Medical License 2012 - 2016
- NM State Medical License 1978 - 1994
- OH State Medical License 1974 - 1986
- American Board of Urology Urology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2006-2013, 2018
- America's Top Doctors for Cancer Castle Connolly, 2005-2013
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Join now to see all
Clinical Trials
- Medical Therapy of Prostatic Symptoms Start of enrollment: 1995 Dec 01
- Consent for Use of Stored Patient Specimens for Future Testing Start of enrollment: 2002 Feb 13
- Radiation Therapy and Cisplatin With or Without Cetuximab in Treating Patients With Stage III or Stage IV Head and Neck Cancer Start of enrollment: 2005 Nov 01
- Join now to see all
Publications & Presentations
PubMed
- 1935 citationsNeoadjuvant Chemotherapy plus Cystectomy Compared with Cystectomy Alone for Locally Advanced Bladder CancerH. Barton Grossman, Ronald B. Natale, Catherine M. Tangen, V. O. Speights, Nicholas J. Vogelzang
The New England Journal of Medicine. 2003-08-28 - 16 citationsCombined low-dose flutamide plus finasteride vs low-dose flutamide monotherapy for recurrent prostate cancer: a comparative analysis of two phase II trials with a long...Lionel L. Bañez, Gary W. Blake, David G. McLeod, E. David Crawford, Judd W. Moul
BJU International. 2009-08-01 - 25 citationsCombination of low-dose flutamide and finasteride for PSA-only recurrent prostate cancer after primary therapy ☆Al Barqawi, Judd W. Moul, Ali M. Ziada, Liann N. Handel, E. David Crawford
Urology. 2003-11-01
Press Mentions
- Prostate Cancer Test from Genomic Health Assesses Risks [NY Times]May 8th, 2013
- Precision Biopsy Names CEO, Announces Clinical-Trial SuccessFebruary 11th, 2013
- FDA Approves Medivation Prostate Cancer DrugAugust 31st, 2012
- Join now to see all
Professional Memberships
- Member
- Member
- American Association for the Advancement of ScienceMember
- Prostate Conditions Education CouncilChairman
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: